| First Author | Lerdkrai C | Year | 2018 |
| Journal | Proc Natl Acad Sci U S A | Volume | 115 |
| Issue | 6 | Pages | E1279-E1288 |
| PubMed ID | 29358403 | Mgi Jnum | J:258288 |
| Mgi Id | MGI:6116567 | Doi | 10.1073/pnas.1714409115 |
| Citation | Lerdkrai C, et al. (2018) Intracellular Ca(2+) stores control in vivo neuronal hyperactivity in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 115(6):E1279-E1288 |
| abstractText | Neuronal hyperactivity is the emerging functional hallmark of Alzheimer''s disease (AD) in both humans and different mouse models, mediating an impairment of memory and cognition. The mechanisms underlying neuronal hyperactivity remain, however, elusive. In vivo Ca(2+) imaging of somatic, dendritic, and axonal activity patterns of cortical neurons revealed that both healthy aging and AD-related mutations augment neuronal hyperactivity. The AD-related enhancement occurred even without amyloid deposition and neuroinflammation, mainly due to presenilin-mediated dysfunction of intracellular Ca(2+) stores in presynaptic boutons, likely causing more frequent activation of synaptic NMDA receptors. In mutant but not wild-type mice, store emptying reduced both the frequency and amplitude of presynaptic Ca(2+) transients and, most importantly, normalized neuronal network activity. Postsynaptically, the store dysfunction was minor and largely restricted to hyperactive cells. These findings identify presynaptic Ca(2+) stores as a key element controlling AD-related neuronal hyperactivity and as a target for disease-modifying treatments. |
